Gene · 990
Papers3,285
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,285
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated Bioinformatics Analysis and Experimental Validation of the Role of Cellular Senescence in Osteoporosis. | Calcif Tissue Int | 2025 | 41361583 | PubTator, text mining | PubMed |
| Interaction between CDC6 and Tmod3 accelerates resistance to paclitaxel through focal adhesion assembly. | Signal Transduct Target Ther | 2025 | 41339304 | PubTator, text mining | PubMed |
| PIK75 effectively reverses PI3K‒AKT activation caused by palbociclib resistance and synergistically inhibits the progression of esophageal squamous cell carcinoma. | Sci Rep | 2025 | 41315778 | PubTator, text mining | PubMed |
| CDC6 promotes the development and progression of clear cell renal cell carcinoma via upregulating RRM2. | Hum Cell | 2025 | 41283970 | PubTator, text mining | PubMed |
| Putrescine functions as a metabolic checkpoint in replication stress-induced senescence. | Cell Mol Life Sci | 2025 | 41258438 | PubTator, text mining | PubMed |
| Integrated machine learning and single-cell analysis identify chromatin-remodeling gene signature for diagnosis and prognosis in nasopharyngeal carcinoma. | Clin Exp Med | 2025 | 41249704 | PubTator, text mining | PubMed |
| SETDB1 is critically required for uveal melanoma growth and represents a promising therapeutic target. | Cell Death Dis | 2025 | 41136387 | PubTator, text mining | PubMed |
| Pathways in the brain, heart and lung influenced by SARS-CoV-2 NSP6 and SARS-CoV-2 regulated miRNAs: an in silico study hinting cancer incidence. | Cardiooncology | 2025 | 41126309 | PubTator, text mining | PubMed |
| Tailor-made 3D in vitro maturation of early antral follicles uncovers cumulus-cell transcriptomic driver signature to predict oocyte competence. | Front Endocrinol (Lausanne) | 2025 | 41103659 | PubTator, text mining | PubMed |
| Transcriptome profiling of human dermal MDPL fibroblasts reveals a characteristic molecular signature providing insights into pathogenic mechanisms. | J Mol Med (Berl) | 2025 | 41083899 | PubTator, text mining | PubMed |
| Spatial mapping of DNA synthesis reveals dynamics and geometry of human replication nanostructures. | EMBO J | 2025 | 41057695 | PubTator, text mining | PubMed |
| EXO1 as a therapeutic target for Fanconi Anaemia, ZRSR2 and BRCA1-A complex deficient cancers. | Nat Commun | 2025 | 41006228 | PubTator, text mining | PubMed |
| CDC6 as a pan-cancer immunological and prognostic biomarker and its role in suppressing melanoma malignancy. | BMC Cancer | 2025 | 40993621 | PubTator, text mining | PubMed |
| Control of the archaeal DNA damage-responsive pathway by phosphorylation of Orc1-2, the global regulator in Saccharolobus islandicus. | Nucleic Acids Res | 2025 | 40973452 | PubTator, text mining | PubMed |
| Glabridin from Glycyrrhiza glabra L. Exhibits Anti-Triple-Negative Breast Cancer Effects by Regulating Various Cell Cycle Genes. | J Agric Food Chem | 2025 | 40955780 | PubTator, text mining | PubMed |
| Temporal control of human DNA replication licensing by CDK4/6-RB signalling and chemical genetics. | Nat Commun | 2025 | 40940326 | PubTator, text mining | PubMed |
| The DNA replication machinery transmits dual signals to prevent unscheduled licensing and execution of centrosome duplication. | Nat Commun | 2025 | 40921755 | PubTator, text mining | PubMed |
| Interrogating the regulatory epigenome of cellular senescence. | Cell Mol Life Sci | 2025 | 40886198 | PubTator, text mining | PubMed |
| Machine learning-based identification of diagnostic and prognostic mitotic cell cycle genes in hepatocellular carcinoma. | PLoS One | 2025 | 40875626 | PubTator, text mining | PubMed |
| Machine learning-driven multi-targeted drug discovery in colon cancer using biomarker signatures. | NPJ Precis Oncol | 2025 | 40847045 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/990/papers?page=3